Providing market intelligence for more than 35 years

In The News

YouTube TV: Millennials will love TV on their phones, trust us!

YouTube TV is also available to watch on laptop and desktop computers, which for many young people equates to the biggest screen in the house.

But at launch, YouTube TV doesn't have support for other streaming devices like Roku or Amazon Fire TV, even though those products are more popular than Chromecast. According to the most recent data from researcher Parks Associates, Roku was the most-purchased line of streaming media players in the US, with a 30 percent share. Amazon's devices just beat out Chromecast, with a 22 percent of sales compared with Chromecast's 21 percent. Apple TV followed at 20 percent.

When CNET asked why YouTube TV is emphasizing mobile even though consumer behavior seems to go the other way, YouTube said that more device support was coming.

From the article "YouTube TV: Millennials will love TV on their phones, trust us!" by Joan E. Solsman.

Previously In The News

Nokia research identifies FWA as big opportunity for 5G

5G Fixed Wireless Access (FWA) is the top-ranked 5G use case among consumers globally—as long as it performs as well as current broadband services, according to new research released by Nokia.  ...

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...